Allopurinol (CAS 315-30-0) is a well-characterized small molecule inhibitor that selectively targets xanthine oxidase an enzyme involved in the oxidative metabolism of hypoxanthine and xanthine to uric acid Through inhibition of this pathway allopurinol reduces uric acid synthesis thereby modulating hyperuricemia It is widely utilized in research investigating purine metabolism and disorders linked to elevated uric acid levels such as chronic gout and urolithiasis This compound serves as a valuable pharmacological tool for elucidating the roles of xanthine oxidase in metabolic and pathophysiological processes